We are live on ! Find out more
DCM

DAFNA Capital Management Portfolio holdings

AUM $440M
1-Year Est. Return 109.12%
This Fund
S&P 500
This Quarter Est. Return
+13.9%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$366M
AUM Growth
+$32.2M
Cap. Flow
+$2.36M
Cap. Flow %
0.64%
Top 10 Hldgs %
49.41%
Holding
80
New
7
Increased
18
Reduced
15
Closed
7

Top Buys

Rank Stock Value
1
DAWN
Day One Biopharmaceuticals
DAWN
+$6.62M
2
TSVT
2seventy bio
TSVT
+$5.26M
3
TNDM icon
Tandem Diabetes Care
TNDM
+$3.54M
4
KURA icon
Kura Oncology
KURA
+$2.93M
5
MRUS
Merus
MRUS
+$2.21M

Top Sells

Rank Stock Value
1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$7.8M
2
CSII
Cardiovascular Systems, Inc.
CSII
+$5.7M
3
APLS
Apellis Pharmaceuticals
APLS
+$3.81M
4
BHVN icon
Biohaven
BHVN
+$3.69M
5
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$2.07M

Sector Composition

Rank Sector Weight
1 Healthcare 82.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORIC icon
76
Oric Pharmaceuticals
ORIC
$1.4B
– –
-170,326
Closed -$971K
THRX
77
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
– –
-131,025
Closed -$1.16M
REUN
78
DELISTED
Reunion Neuroscience Inc. Common Shares
REUN
– –
-12,598
Closed -$8.7K
CSII
79
DELISTED
Cardiovascular Systems, Inc.
CSII
– –
-286,988
Closed -$5.7M
1 2 3
4

Similar funds

CDMG
Creek Drive Management Group San Francisco, California $439M AUM
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
WAS
Winch Advisory Services Appleton, Wisconsin $438M AUM 17.59% 1-Year Est. Return
DBG
De Burlo Group Boston, Massachusetts $441M AUM 21.21% 1-Year Est. Return

DAFNA Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, DAFNA Capital Management held 80 positions worth $366M, up 9.7% from $334M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

DAFNA Capital Management's Q2 2023 filing shows 7 new, 18 increased, 15 reduced and 7 closed positions. Its largest new stake was Day One Biopharmaceuticals: 507,100 shares worth $6.05M. The largest sale was Karuna Therapeutics, Inc. Common Stock, an estimated $7.8M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, up from 81% a quarter earlier.

  • DAFNA Capital Management's largest Q2 2023 buy was Day One Biopharmaceuticals: 507,100 shares worth $6.05M.
  • DAFNA Capital Management added most to Kura Oncology in Q2 2023, an estimated $2.93M increase.
  • DAFNA Capital Management's biggest Q2 2023 reduction was Karuna Therapeutics, Inc. Common Stock, cutting an estimated $7.8M.
  • DAFNA Capital Management fully exited Cardiovascular Systems, Inc. in Q2 2023, selling an estimated $5.7M.
  • DAFNA Capital Management's ten largest holdings make up 49% of its $366M portfolio in Q2 2023.
  • DAFNA Capital Management opened 7 new positions and closed 7 in Q2 2023.
  • DAFNA Capital Management's portfolio value rose 9.7% quarter-over-quarter to $366M.

Based on DAFNA Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.